Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) dropped 7.9% during trading on Wednesday . The stock traded as low as $12.85 and last traded at $13.02. Approximately 51,648 shares were traded during mid-day trading, a decline of 59% from the average daily volume of 126,006 shares. The stock had previously closed at $14.13. Analysts Set […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 2,940,000 shares, an increase of 7.3% from the April 15th total of 2,740,000 shares. Based on an average daily trading volume, of 69,500 shares, […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 2,940,000 shares, a growth of 7.3% from the April 15th total of 2,740,000 shares. Based on an average daily trading volume, of 69,500 shares, […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) – Equities researchers at HC Wainwright issued their Q1 2024 earnings estimates for Janux Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst S. Ramakanth expects that the company will post earnings per share of ($0.57) for the quarter. HC […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) – Research analysts at HC Wainwright lifted their Q2 2023 earnings estimates for shares of Janux Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.51) per share for the quarter, […]